Titre:
  • Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer
Auteur:Woff, Erwin; Hendlisz, Alain; Ameye, Lieveke; Garcia, Camilo; Kamoun, Tarek; Guiot, Thomas; Paesmans, Marianne; Flamen, Patrick
Informations sur la publication:The Journal of nuclear medicine, 60, 2, page (178-184)
Statut de publication:Publié, 2019-02-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:FDG PET/CT
Oncology: GI
PET/CT
metabolic active tumor volume
metastatic colorectal cancer
multikinase inhibitors
total lesion glycolysis
MeSH keywords:Adult
Aged
Aged, 80 and over
Biomarkers -- metabolism
Colonic Neoplasms -- diagnostic imaging -- drug therapy -- metabolism -- pathology
Female
Fluorodeoxyglucose F18
Glycolysis -- drug effects
Humans
Male
Middle Aged
Neoplasm Metastasis
Positron Emission Tomography Computed Tomography
Prognosis
Protein Kinase Inhibitors -- pharmacology -- therapeutic use
Retrospective Studies
Survival Analysis
Treatment Failure
Tumor Burden -- drug effects
Langue:Anglais
Identificateurs:urn:issn:0161-5505
info:doi/10.2967/jnumed.118.210161
info:pii/jnumed.118.210161
info:pmid/29959212